This inference has been preliminarily verified in our small cohort study, which is reflected in that the moderate-dose of methylprednisolone could significantly increase the PaO2/FiO2 ratio and reduce the CRP level in patients with moderate and severe ARDS compared with the other two doses. This evidence concerns the gene CRP and acute respiratory distress syndrome.